Home » Featured Articles » How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials
Most Recent Flipbooks
Successful Oncology Trials Need Intelligent Supply Management
eConsent Tearing Down Barriers to Oncology Trials
Journal for Clinical Studies Article: eConsent: Tearing Down Barriers to Oncology Trials, co-authored by Neetu Pundir & Bill Byrom, Signant Health.
Power of Mobile Technology to Optimize Patient Engagement
Power of Mobile Technology to Optimize Patient Engagement and Study Success, article, authored by Neetu Pundir, Signant Health, published in the Journal for Clinical Studies.
The Case for Integrated IRT
An integrated just-in-time interactive response technology (IRT) interface can help companies reduce the costs of maintaining adequate buffers in their clinical supply chain.
ePRO for the Modern Trial: Considerations to Implementing a BYOD or Partial Provisioning Strategy
Improving Outcomes in Diabetes Research
Leveraging Technology to Develop New Trial Endpoints
eConsent Regulatory Myths_PME_NPundir
Optimizing Outcomes - Reduce the Burden of Data Collection - Oncology
An IRB Perspective on Improving Informed Consent
What the Future Holds for Informed Consent
Recruitment & Retention: Breaking Down the Barriers to eConsent Adoption
In Pursuit of eConsent: Best Practice Recommendations for Successful Integration
eConsent: 5 Key Areas of Preparation
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
Successful Adoption of eConsent Best Practices for Integrating eConsent Technology